Insights

Strategic fit 2seventy bio is part of Bristol Myers Squibb, indicating potential alignment for enterprise collaborations, co-development opportunities, and joint ventures in CART cell therapy and related biotechnologies.

Clinical risk signals Recent news references pauses in autoimmune CAR-T trials due to patient deaths and side effects, suggesting a market need for enhanced safety analytics, data monitoring, and risk management solutions to restore trial confidence.

Manufacturing expansion BMS expansions in radiopharmaceutical manufacturing facilities in Indiana signal ongoing demand for scalable process development, quality control, and manufacturing software to support new production lines.

Technology stack Adoption of tools like MATLAB, New Relic, Grafana, and UiPath points to opportunities for sales in data analytics, automation, observability, and workflow automation solutions tailored to biotech R&D and manufacturing.

Funding and growth Significant funding activity and strategic investments by BMS in biotech ventures indicate a favorable environment for partnerships, licensing deals, and technology integration opportunities with startups and portfolio companies.

Similar companies to 2seventy bio

2seventy bio Tech Stack

2seventy bio uses 8 technology products and services including MATLAB, Grafana, Microsoft Power Apps, and more. Explore 2seventy bio's tech stack below.

Media & News

2seventy bio's Email Address Formats

2seventy bio uses at least 7 email formats:
2seventy bio Email FormatsExamplePercentage
First.Last@2seventybio.comJohn.Doe@2seventybio.com
98%
First.Middle@2seventybio.comJohn.Michael@2seventybio.com
1%
First.L@2seventybio.comJohn.D@2seventybio.com
1%
First.Last@bms.comJohn.Doe@bms.com
91%
LastF@bms.comDoeJ@bms.com
5%
First@bms.comJohn@bms.com
2%
Last.First@bms.comDoe.John@bms.com
2%

Frequently Asked Questions

What is 2seventy bio's stock symbol?

Minus sign iconPlus sign icon
2seventy bio is a publicly traded company; the company's stock symbol is TSVT.

What is 2seventy bio's official website and social media links?

Minus sign iconPlus sign icon
2seventy bio's official website is bms.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does 2seventy bio generate?

Minus sign iconPlus sign icon
As of October 2026, 2seventy bio's annual revenue is estimated to be $25M - $50M.

What is 2seventy bio's SIC code and NAICS code?

Minus sign iconPlus sign icon
2seventy bio's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does 2seventy bio have currently?

Minus sign iconPlus sign icon
As of October 2026, 2seventy bio has approximately 60 employees across 1 continents, including North America. Key team members include Chief People Officer: K. W., Chief Operating Officer: W. B. and Senior Vice President Clinical Development: A. T. Explore 2seventy bio's employee directory with LeadIQ.

What industry does 2seventy bio belong to?

Minus sign iconPlus sign icon
2seventy bio operates in the Biotechnology Research industry.

What technology does 2seventy bio use?

Minus sign iconPlus sign icon
2seventy bio's tech stack includes MATLAB, Grafana, Microsoft Power Apps, UiPath, Lucidchart, Procore, New Relic and Cursor Code Editor.

What is 2seventy bio's email format?

Minus sign iconPlus sign icon
2seventy bio's email format typically follows the pattern of First.Last@2seventybio.com. Find more 2seventy bio email formats with LeadIQ.

How much funding has 2seventy bio raised to date?

Minus sign iconPlus sign icon
As of October 2026, 2seventy bio has raised $315M in funding. The last funding round occurred on Feb 28, 2023 for $125M.

When was 2seventy bio founded?

Minus sign iconPlus sign icon
2seventy bio was founded in 2021.
2seventy bio logo

2seventy bio

Biotechnology ResearchMassachusetts, United States51-200 Employees

2seventy bio is a mid-sized biotechnology research company based in Cambridge, Massachusetts. It was integrated into Bristol Myers Squibb, placing its activities within a global biopharmaceutical framework. Public-facing materials reference CART cell therapy in connection with its association with BMS.

In this arrangement, 2seventy bio operates within Bristol Myers Squibb's broader biopharmaceutical research ecosystem. The available news items relate to the parent company’s leadership moves and clinical programs, illustrating the corporate context surrounding the integrated entity.

Section iconCompany Overview

Website
bms.com
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
TSVT
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2021
Employees
51-200

Section iconFunding & Financials

  • $315M

    2seventy bio has raised a total of $315M of funding over 3 rounds. Their latest funding round was raised on Feb 28, 2023 in the amount of $125M as a Post IPO Equity.

  • $25M - $50M

    2seventy bio's revenue is estimated to be in the range of $25M - $50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.